Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer

Clinical trial NCT00272038 · COMPLETED

Trial details

NCT number: NCT00272038
Sponsor: Oncology Specialists, S.C.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2005-12-01
Primary completion: 2010-10-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.